An activated factor VII variant with enhanced tissue factor-independent activity speeds wound healing in a mouse hemophilia B model.

dc.contributor.author

Hoffman, M

dc.contributor.author

Chang, J-Y

dc.contributor.author

Ezban, M

dc.contributor.author

Monroe, DM

dc.coverage.spatial

England

dc.date.accessioned

2018-01-01T14:59:48Z

dc.date.available

2018-01-01T14:59:48Z

dc.date.issued

2016-06

dc.description.abstract

UNLABELLED: Essentials Disorders of hemostasis can lead to delayed and defective wound healing. In hemophilia B (HB) mice, 7 days of Factor (F)IX or VIIa are needed to normalize wound healing. One dose of a highly active FVIIa variant (DVQ) restored normal wound closure time in HB mice. Coagulation factors with enhanced activity may acquire biological effects not due to hemostasis. SUMMARY: Introduction We have previously reported that hemophilia B (HB) mice have delayed healing of cutaneous wounds and alterations in wound histology. Administration of a single dose of either factor IX or recombinant activated FVII (rFVIIa) (NovoSeven) prior to wounding did not improve wound closure time or histology. The FVIIa analog DVQ (V158D, E296V and M298Q mutations) was designed to have higher tissue factor-independent activity than rVIIa. We hypothesized that a single dose of DVQ would be more effective in restoring wound healing in HB mice. Methods Cutaneous punch wounds were made on the backs of HB and wild-type mice, and the time to wound closure was monitored. HB mice were treated with a dose of rFVIIa (10 mg kg(-1) ) or DVQ (1 mg kg(-1) ) that corrected the tail bleeding time. Skin samples were taken at various time points after wounding, fixed, and stained, and the histology was examined. Results As previously reported, wound closure times in HB mice given one dose of rFVIIa were not improved over those in untreated HB mice. Surprisingly, healing times in HB mice treated with an equally hemostatic dose of DVQ were normalized to that in wild-type mice. However, DVQ did not correct all histologic abnormalities in HB mice. Conclusions As the doses of DVQ and rFVIIa were chosen to support comparable levels of hemostasis, our data suggest that the improved healing seen with DVQ is not solely attributable to its hemostatic activity. It is possible that the improved wound healing arises through the effect of DVQ on cell signaling mechanisms.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/26952654

dc.identifier.eissn

1538-7836

dc.identifier.uri

https://hdl.handle.net/10161/15926

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

J Thromb Haemost

dc.relation.isversionof

10.1111/jth.13311

dc.subject

angiogenesis inhibitors

dc.subject

epithelium

dc.subject

hemophilia

dc.subject

hemostasis

dc.subject

thrombin

dc.title

An activated factor VII variant with enhanced tissue factor-independent activity speeds wound healing in a mouse hemophilia B model.

dc.type

Journal article

duke.contributor.orcid

Hoffman, M|0000-0001-7123-0100

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/26952654

pubs.begin-page

1249

pubs.end-page

1254

pubs.issue

6

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Immunology

pubs.organisational-group

Pathology

pubs.organisational-group

School of Medicine

pubs.organisational-group

Temp group - logins allowed

pubs.publication-status

Published

pubs.volume

14

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
16 JTH DVQProof.pdf
Size:
408.9 KB
Format:
Adobe Portable Document Format
Description:
Accepted version